Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Shire Pharmaceuticals Inc's peak revenue was $15.2B in 2017. The peak quarterly revenue was $4.1B in 2017(q4).
Shire Pharmaceuticals Inc's revenue increased from $1.2b in 2003 to $15.2B currently. That's a 1,151.32% change in annual revenue.
| Fiscal year / year | Shire Pharmaceuticals Inc revenue |
|---|---|
| 2009 | $3.0B |
| 2010 | $3.5B |
| 2011 | $4.2B |
| 2012 | $4.5B |
| 2013 | $4.9B |
| 2014 | $6.0B |
| 2015 | $6.4B |
| 2016 | $11.4B |
| 2017 | $15.2B |
Rate Shire Pharmaceuticals Inc's financial transparency
Shire Pharmaceuticals Inc saw the greatest revenue growth in 2016, when revenue increased by 77.61%.
Shire Pharmaceuticals Inc had the lowest revenue growth in 2009, when revenue changed by -0.48%.
| Year | Shire Pharmaceuticals Inc growth |
|---|---|
| 2009 | -0%↓ |
| 2010 | 15%↑ |
| 2011 | 20%↑ |
| 2012 | 9%↑ |
| 2013 | 9%↑ |
| 2014 | 22%↑ |
| 2015 | 7%↑ |
| 2016 | 78%↑ |
| 2017 | 33%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $817.8M | $629.7M | $667.0M | $893.3M |
| 2010 | $816.2M | $849.4M | $874.3M | $931.2M |
| 2011 | $972.2M | $1.1B | $1.1B | $1.0B |
| 2012 | $1.2B | $1.2B | $1.1B | $1.0B |
| 2013 | $1.1B | $1.3B | $1.2B | $1.3B |
| 2014 | $1.3B | $1.5B | $1.6B | $1.6B |
| 2015 | $1.5B | $1.6B | $1.7B | $1.7B |
| 2016 | $1.7B | $2.4B | $3.5B | $3.8B |
| 2017 | $3.6B | $3.7B | $3.7B | $4.1B |
| 2018 | $3.8B | $3.9B | $3.9B | - |
Do you work at Shire Pharmaceuticals Inc?
Is Shire Pharmaceuticals Inc transparent about its revenue structure?
| CEO | Flemming Ornskov |
| Company Type | Private |
| Employees Number | 3,500 |
| Date Founded | 2004 |
| Headquarters | Wayne, Pennsylvania |
| Number of Locations | 3 |
| Revenue | $15.2B |
| Net Income | $4,271,500,000 |
| Gross Proft | $10.5B (2017) |
| Tax Rate | -1.2% |
| Total Assets | $67,756,900,000 |
| Ticker | SHPGF |
Shire Pharmaceuticals Inc's top competitor, Mylan, earned an annual revenue of $11.5B.
Shire Pharmaceuticals Inc's smallest competitor is Enzon Pharmaceuticals with revenue of $26.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Lumos Pharma | $67,852 | $2.1M | 20 | 2 |
| Oyster Point Pharma | $44,982 | $2.2M | 86 | - |
| Astellas Pharma | $90,808 | $11.1B | 17,217 | 266 |
| Watson Pharma Pvt Ltd | $79,372 | $5.9B | 21,600 | - |
| Mylan | $66,113 | $11.5B | 35,000 | 1 |
| UCB | $67,621 | $5.7B | 7,600 | 82 |
| Alexion Pharmaceuticals | $92,699 | $6.1B | 2,525 | 49 |
| SmithKline Beecham Holdings Corporation | $72,982 | - | 1,500 | - |
| Incyte | $103,592 | $4.2B | 1,600 | 42 |
| Cyberonics | $86,285 | $291.6M | 660 | - |
Zippia gives an in-depth look into the details of Shire Pharmaceuticals Inc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Shire Pharmaceuticals Inc. The employee data is based on information from people who have self-reported their past or current employments at Shire Pharmaceuticals Inc. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Shire Pharmaceuticals Inc. The data presented on this page does not represent the view of Shire Pharmaceuticals Inc and its employees or that of Zippia.
Shire Pharmaceuticals Inc may also be known as or be related to Shire Pharmaceuticals and Shire Pharmaceuticals Inc.